[Newsmaker] Samsung BioLogics CEO apologizes, pledges to minimize fallout from accounting fraud ruling
IndustryNov 30, 2018
Samsung BioLogics CEO Kim Tae-han on Friday apologized to the shareholders for inconveniences caused by the recent accounting fraud ruling issued by South Korea’s Securities and Futures Commission, pledging to do his best to minimize damage to the firm’s valuation and business activities. “We apologize for any inconvenience that you have suffered in exercising property rights as a result of the suspension of trading of shares due to the SFC’s unwillingness to recognize the Company’s transparency